EastWest Bioscience Inc. announced earnings results for the third quarter ended April 30, 2020. For the third quarter, the company announced total revenue was CAD 138,685 compared to CAD 478,692 a year ago. Net loss was CAD 374,690 compared to CAD 828,045 a year ago. Basic eps - continuing operations was CAD 0 compared to basic loss per share from continuing operations of CAD 0.01 a year ago. For the nine months, total revenue was CAD 794,576 compared to CAD 915,681 a year ago. Net loss was CAD 841,062 compared to CAD 2.430 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.03 a year ago.